1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Radioimmunotherapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030 1.2.2 Beta-emitting 1.2.3 Targeted Alpha Therapy 1.3 Market by Application 1.3.1 Global Radioimmunotherapy Market Growth by Application: 2019 VS 2023 VS 2030 1.3.2 Solid Tumor 1.3.3 Non Hodgkin Lymphoma 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Radioimmunotherapy Market Perspective (2019-2030) 2.2 Radioimmunotherapy Growth Trends by Region 2.2.1 Global Radioimmunotherapy Market Size by Region: 2019 VS 2023 VS 2030 2.2.2 Radioimmunotherapy Historic Market Size by Region (2019-2024) 2.2.3 Radioimmunotherapy Forecasted Market Size by Region (2025-2030) 2.3 Radioimmunotherapy Market Dynamics 2.3.1 Radioimmunotherapy Industry Trends 2.3.2 Radioimmunotherapy Market Drivers 2.3.3 Radioimmunotherapy Market Challenges 2.3.4 Radioimmunotherapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Radioimmunotherapy Players by Revenue 3.1.1 Global Top Radioimmunotherapy Players by Revenue (2019-2024) 3.1.2 Global Radioimmunotherapy Revenue Market Share by Players (2019-2024) 3.2 Global Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Radioimmunotherapy Revenue 3.4 Global Radioimmunotherapy Market Concentration Ratio 3.4.1 Global Radioimmunotherapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Radioimmunotherapy Revenue in 2023 3.5 Radioimmunotherapy Key Players Head office and Area Served 3.6 Key Players Radioimmunotherapy Product Solution and Service 3.7 Date of Enter into Radioimmunotherapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Radioimmunotherapy Breakdown Data by Type 4.1 Global Radioimmunotherapy Historic Market Size by Type (2019-2024) 4.2 Global Radioimmunotherapy Forecasted Market Size by Type (2025-2030) 5 Radioimmunotherapy Breakdown Data by Application 5.1 Global Radioimmunotherapy Historic Market Size by Application (2019-2024) 5.2 Global Radioimmunotherapy Forecasted Market Size by Application (2025-2030) 6 North America 6.1 North America Radioimmunotherapy Market Size (2019-2030) 6.2 North America Radioimmunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030 6.3 North America Radioimmunotherapy Market Size by Country (2019-2024) 6.4 North America Radioimmunotherapy Market Size by Country (2025-2030) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Radioimmunotherapy Market Size (2019-2030) 7.2 Europe Radioimmunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030 7.3 Europe Radioimmunotherapy Market Size by Country (2019-2024) 7.4 Europe Radioimmunotherapy Market Size by Country (2025-2030) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Radioimmunotherapy Market Size (2019-2030) 8.2 Asia-Pacific Radioimmunotherapy Market Growth Rate by Region: 2019 VS 2023 VS 2030 8.3 Asia-Pacific Radioimmunotherapy Market Size by Region (2019-2024) 8.4 Asia-Pacific Radioimmunotherapy Market Size by Region (2025-2030) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Radioimmunotherapy Market Size (2019-2030) 9.2 Latin America Radioimmunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030 9.3 Latin America Radioimmunotherapy Market Size by Country (2019-2024) 9.4 Latin America Radioimmunotherapy Market Size by Country (2025-2030) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Radioimmunotherapy Market Size (2019-2030) 10.2 Middle East & Africa Radioimmunotherapy Market Growth Rate by Country: 2019 VS 2023 VS 2030 10.3 Middle East & Africa Radioimmunotherapy Market Size by Country (2019-2024) 10.4 Middle East & Africa Radioimmunotherapy Market Size by Country (2025-2030) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Bayer 11.1.1 Bayer Company Detail 11.1.2 Bayer Business Overview 11.1.3 Bayer Radioimmunotherapy Introduction 11.1.4 Bayer Revenue in Radioimmunotherapy Business (2019-2024) 11.1.5 Bayer Recent Development 11.2 Novartis 11.2.1 Novartis Company Detail 11.2.2 Novartis Business Overview 11.2.3 Novartis Radioimmunotherapy Introduction 11.2.4 Novartis Revenue in Radioimmunotherapy Business (2019-2024) 11.2.5 Novartis Recent Development 11.3 Lantheus 11.3.1 Lantheus Company Detail 11.3.2 Lantheus Business Overview 11.3.3 Lantheus Radioimmunotherapy Introduction 11.3.4 Lantheus Revenue in Radioimmunotherapy Business (2019-2024) 11.3.5 Lantheus Recent Development 11.4 Aurobindo Pharma 11.4.1 Aurobindo Pharma Company Detail 11.4.2 Aurobindo Pharma Business Overview 11.4.3 Aurobindo Pharma Radioimmunotherapy Introduction 11.4.4 Aurobindo Pharma Revenue in Radioimmunotherapy Business (2019-2024) 11.4.5 Aurobindo Pharma Recent Development 11.5 Mundipharma 11.5.1 Mundipharma Company Detail 11.5.2 Mundipharma Business Overview 11.5.3 Mundipharma Radioimmunotherapy Introduction 11.5.4 Mundipharma Revenue in Radioimmunotherapy Business (2019-2024) 11.5.5 Mundipharma Recent Development 11.6 China Isotope & Radiation 11.6.1 China Isotope & Radiation Company Detail 11.6.2 China Isotope & Radiation Business Overview 11.6.3 China Isotope & Radiation Radioimmunotherapy Introduction 11.6.4 China Isotope & Radiation Revenue in Radioimmunotherapy Business (2019-2024) 11.6.5 China Isotope & Radiation Recent Development 11.7 Curium Pharmaceuticals 11.7.1 Curium Pharmaceuticals Company Detail 11.7.2 Curium Pharmaceuticals Business Overview 11.7.3 Curium Pharmaceuticals Radioimmunotherapy Introduction 11.7.4 Curium Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) 11.7.5 Curium Pharmaceuticals Recent Development 11.8 Gilead Sciences 11.8.1 Gilead Sciences Company Detail 11.8.2 Gilead Sciences Business Overview 11.8.3 Gilead Sciences Radioimmunotherapy Introduction 11.8.4 Gilead Sciences Revenue in Radioimmunotherapy Business (2019-2024) 11.8.5 Gilead Sciences Recent Development 11.9 Clarity Pharmaceuticals 11.9.1 Clarity Pharmaceuticals Company Detail 11.9.2 Clarity Pharmaceuticals Business Overview 11.9.3 Clarity Pharmaceuticals Radioimmunotherapy Introduction 11.9.4 Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) 11.9.5 Clarity Pharmaceuticals Recent Development 11.10 Curasight 11.10.1 Curasight Company Detail 11.10.2 Curasight Business Overview 11.10.3 Curasight Radioimmunotherapy Introduction 11.10.4 Curasight Revenue in Radioimmunotherapy Business (2019-2024) 11.10.5 Curasight Recent Development 11.11 Nordic Nanovector 11.11.1 Nordic Nanovector Company Detail 11.11.2 Nordic Nanovector Business Overview 11.11.3 Nordic Nanovector Radioimmunotherapy Introduction 11.11.4 Nordic Nanovector Revenue in Radioimmunotherapy Business (2019-2024) 11.11.5 Nordic Nanovector Recent Development 11.12 Philogen 11.12.1 Philogen Company Detail 11.12.2 Philogen Business Overview 11.12.3 Philogen Radioimmunotherapy Introduction 11.12.4 Philogen Revenue in Radioimmunotherapy Business (2019-2024) 11.12.5 Philogen Recent Development 11.13 RadioMedix 11.13.1 RadioMedix Company Detail 11.13.2 RadioMedix Business Overview 11.13.3 RadioMedix Radioimmunotherapy Introduction 11.13.4 RadioMedix Revenue in Radioimmunotherapy Business (2019-2024) 11.13.5 RadioMedix Recent Development 11.14 Telix Pharmaceuticals 11.14.1 Telix Pharmaceuticals Company Detail 11.14.2 Telix Pharmaceuticals Business Overview 11.14.3 Telix Pharmaceuticals Radioimmunotherapy Introduction 11.14.4 Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) 11.14.5 Telix Pharmaceuticals Recent Development 11.15 Orano Med 11.15.1 Orano Med Company Detail 11.15.2 Orano Med Business Overview 11.15.3 Orano Med Radioimmunotherapy Introduction 11.15.4 Orano Med Revenue in Radioimmunotherapy Business (2019-2024) 11.15.5 Orano Med Recent Development 11.16 Actinium Pharmaceuticals 11.16.1 Actinium Pharmaceuticals Company Detail 11.16.2 Actinium Pharmaceuticals Business Overview 11.16.3 Actinium Pharmaceuticals Radioimmunotherapy Introduction 11.16.4 Actinium Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) 11.16.5 Actinium Pharmaceuticals Recent Development 11.17 Y-mAbs Therapeutics 11.17.1 Y-mAbs Therapeutics Company Detail 11.17.2 Y-mAbs Therapeutics Business Overview 11.17.3 Y-mAbs Therapeutics Radioimmunotherapy Introduction 11.17.4 Y-mAbs Therapeutics Revenue in Radioimmunotherapy Business (2019-2024) 11.17.5 Y-mAbs Therapeutics Recent Development 11.18 Fusion Pharmaceuticals 11.18.1 Fusion Pharmaceuticals Company Detail 11.18.2 Fusion Pharmaceuticals Business Overview 11.18.3 Fusion Pharmaceuticals Radioimmunotherapy Introduction 11.18.4 Fusion Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) 11.18.5 Fusion Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Radioimmunotherapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030 Table 2. Key Players of Beta-emitting Table 3. Key Players of Targeted Alpha Therapy Table 4. Global Radioimmunotherapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030 Table 5. Global Radioimmunotherapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Radioimmunotherapy Market Size by Region (2019-2024) & (US$ Million) Table 7. Global Radioimmunotherapy Market Share by Region (2019-2024) Table 8. Global Radioimmunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 9. Global Radioimmunotherapy Market Share by Region (2025-2030) Table 10. Radioimmunotherapy Market Trends Table 11. Radioimmunotherapy Market Drivers Table 12. Radioimmunotherapy Market Challenges Table 13. Radioimmunotherapy Market Restraints Table 14. Global Radioimmunotherapy Revenue by Players (2019-2024) & (US$ Million) Table 15. Global Radioimmunotherapy Market Share by Players (2019-2024) Table 16. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2023) Table 17. Ranking of Global Top Radioimmunotherapy Companies by Revenue (US$ Million) in 2023 Table 18. Global 5 Largest Players Market Share by Radioimmunotherapy Revenue (CR5 and HHI) & (2019-2024) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Radioimmunotherapy Product Solution and Service Table 21. Date of Enter into Radioimmunotherapy Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Radioimmunotherapy Market Size by Type (2019-2024) & (US$ Million) Table 24. Global Radioimmunotherapy Revenue Market Share by Type (2019-2024) Table 25. Global Radioimmunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 26. Global Radioimmunotherapy Revenue Market Share by Type (2025-2030) Table 27. Global Radioimmunotherapy Market Size by Application (2019-2024) & (US$ Million) Table 28. Global Radioimmunotherapy Revenue Market Share by Application (2019-2024) Table 29. Global Radioimmunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 30. Global Radioimmunotherapy Revenue Market Share by Application (2025-2030) Table 31. North America Radioimmunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 Table 32. North America Radioimmunotherapy Market Size by Country (2019-2024) & (US$ Million) Table 33. North America Radioimmunotherapy Market Size by Country (2025-2030) & (US$ Million) Table 34. Europe Radioimmunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 Table 35. Europe Radioimmunotherapy Market Size by Country (2019-2024) & (US$ Million) Table 36. Europe Radioimmunotherapy Market Size by Country (2025-2030) & (US$ Million) Table 37. Asia-Pacific Radioimmunotherapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030 Table 38. Asia-Pacific Radioimmunotherapy Market Size by Region (2019-2024) & (US$ Million) Table 39. Asia-Pacific Radioimmunotherapy Market Size by Region (2025-2030) & (US$ Million) Table 40. Latin America Radioimmunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 Table 41. Latin America Radioimmunotherapy Market Size by Country (2019-2024) & (US$ Million) Table 42. Latin America Radioimmunotherapy Market Size by Country (2025-2030) & (US$ Million) Table 43. Middle East & Africa Radioimmunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 Table 44. Middle East & Africa Radioimmunotherapy Market Size by Country (2019-2024) & (US$ Million) Table 45. Middle East & Africa Radioimmunotherapy Market Size by Country (2025-2030) & (US$ Million) Table 46. Bayer Company Detail Table 47. Bayer Business Overview Table 48. Bayer Radioimmunotherapy Product Table 49. Bayer Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 50. Bayer Recent Development Table 51. Novartis Company Detail Table 52. Novartis Business Overview Table 53. Novartis Radioimmunotherapy Product Table 54. Novartis Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 55. Novartis Recent Development Table 56. Lantheus Company Detail Table 57. Lantheus Business Overview Table 58. Lantheus Radioimmunotherapy Product Table 59. Lantheus Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 60. Lantheus Recent Development Table 61. Aurobindo Pharma Company Detail Table 62. Aurobindo Pharma Business Overview Table 63. Aurobindo Pharma Radioimmunotherapy Product Table 64. Aurobindo Pharma Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 65. Aurobindo Pharma Recent Development Table 66. Mundipharma Company Detail Table 67. Mundipharma Business Overview Table 68. Mundipharma Radioimmunotherapy Product Table 69. Mundipharma Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 70. Mundipharma Recent Development Table 71. China Isotope & Radiation Company Detail Table 72. China Isotope & Radiation Business Overview Table 73. China Isotope & Radiation Radioimmunotherapy Product Table 74. China Isotope & Radiation Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 75. China Isotope & Radiation Recent Development Table 76. Curium Pharmaceuticals Company Detail Table 77. Curium Pharmaceuticals Business Overview Table 78. Curium Pharmaceuticals Radioimmunotherapy Product Table 79. Curium Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 80. Curium Pharmaceuticals Recent Development Table 81. Gilead Sciences Company Detail Table 82. Gilead Sciences Business Overview Table 83. Gilead Sciences Radioimmunotherapy Product Table 84. Gilead Sciences Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 85. Gilead Sciences Recent Development Table 86. Clarity Pharmaceuticals Company Detail Table 87. Clarity Pharmaceuticals Business Overview Table 88. Clarity Pharmaceuticals Radioimmunotherapy Product Table 89. Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 90. Clarity Pharmaceuticals Recent Development Table 91. Curasight Company Detail Table 92. Curasight Business Overview Table 93. Curasight Radioimmunotherapy Product Table 94. Curasight Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 95. Curasight Recent Development Table 96. Nordic Nanovector Company Detail Table 97. Nordic Nanovector Business Overview Table 98. Nordic Nanovector Radioimmunotherapy Product Table 99. Nordic Nanovector Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 100. Nordic Nanovector Recent Development Table 101. Philogen Company Detail Table 102. Philogen Business Overview Table 103. Philogen Radioimmunotherapy Product Table 104. Philogen Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 105. Philogen Recent Development Table 106. RadioMedix Company Detail Table 107. RadioMedix Business Overview Table 108. RadioMedix Radioimmunotherapy Product Table 109. RadioMedix Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 110. RadioMedix Recent Development Table 111. Telix Pharmaceuticals Company Detail Table 112. Telix Pharmaceuticals Business Overview Table 113. Telix Pharmaceuticals Radioimmunotherapy Product Table 114. Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 115. Telix Pharmaceuticals Recent Development Table 116. Orano Med Company Detail Table 117. Orano Med Business Overview Table 118. Orano Med Radioimmunotherapy Product Table 119. Orano Med Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 120. Orano Med Recent Development Table 121. Actinium Pharmaceuticals Company Detail Table 122. Actinium Pharmaceuticals Business Overview Table 123. Actinium Pharmaceuticals Radioimmunotherapy Product Table 124. Actinium Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 125. Actinium Pharmaceuticals Recent Development Table 126. Y-mAbs Therapeutics Company Detail Table 127. Y-mAbs Therapeutics Business Overview Table 128. Y-mAbs Therapeutics Radioimmunotherapy Product Table 129. Y-mAbs Therapeutics Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 130. Y-mAbs Therapeutics Recent Development Table 131. Fusion Pharmaceuticals Company Detail Table 132. Fusion Pharmaceuticals Business Overview Table 133. Fusion Pharmaceuticals Radioimmunotherapy Product Table 134. Fusion Pharmaceuticals Revenue in Radioimmunotherapy Business (2019-2024) & (US$ Million) Table 135. Fusion Pharmaceuticals Recent Development Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Global Radioimmunotherapy Market Size Comparison by Type (2024-2030) & (US$ Million) Figure 2. Global Radioimmunotherapy Market Share by Type: 2023 VS 2030 Figure 3. Beta-emitting Features Figure 4. Targeted Alpha Therapy Features Figure 5. Global Radioimmunotherapy Market Size Comparison by Application (2024-2030) & (US$ Million) Figure 6. Global Radioimmunotherapy Market Share by Application: 2023 VS 2030 Figure 7. Solid Tumor Case Studies Figure 8. Non Hodgkin Lymphoma Case Studies Figure 9. Radioimmunotherapy Report Years Considered Figure 10. Global Radioimmunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 11. Global Radioimmunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 12. Global Radioimmunotherapy Market Share by Region: 2023 VS 2030 Figure 13. Global Radioimmunotherapy Market Share by Players in 2023 Figure 14. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2023) Figure 15. The Top 10 and 5 Players Market Share by Radioimmunotherapy Revenue in 2023 Figure 16. North America Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 17. North America Radioimmunotherapy Market Share by Country (2019-2030) Figure 18. United States Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 19. Canada Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 20. Europe Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 21. Europe Radioimmunotherapy Market Share by Country (2019-2030) Figure 22. Germany Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 23. France Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 24. U.K. Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 25. Italy Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 26. Russia Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 27. Nordic Countries Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 28. Asia-Pacific Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 29. Asia-Pacific Radioimmunotherapy Market Share by Region (2019-2030) Figure 30. China Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. Japan Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. South Korea Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. Southeast Asia Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 34. India Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 35. Australia Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 36. Latin America Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 37. Latin America Radioimmunotherapy Market Share by Country (2019-2030) Figure 38. Mexico Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 39. Brazil Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 40. Middle East & Africa Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 41. Middle East & Africa Radioimmunotherapy Market Share by Country (2019-2030) Figure 42. Turkey Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. Saudi Arabia Radioimmunotherapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 44. Bayer Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 45. Novartis Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 46. Lantheus Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 47. Aurobindo Pharma Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 48. Mundipharma Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 49. China Isotope & Radiation Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 50. Curium Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 51. Gilead Sciences Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 52. Clarity Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 53. Curasight Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 54. Nordic Nanovector Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 55. Philogen Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 56. RadioMedix Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 57. Telix Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 58. Orano Med Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 59. Actinium Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 60. Y-mAbs Therapeutics Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 61. Fusion Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2019-2024) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed